US20020031482A1 - Combination of erythrulose and a reducing sugar with self-tanning properties - Google Patents
Combination of erythrulose and a reducing sugar with self-tanning properties Download PDFInfo
- Publication number
- US20020031482A1 US20020031482A1 US09/380,651 US38065100A US2002031482A1 US 20020031482 A1 US20020031482 A1 US 20020031482A1 US 38065100 A US38065100 A US 38065100A US 2002031482 A1 US2002031482 A1 US 2002031482A1
- Authority
- US
- United States
- Prior art keywords
- erythrulose
- self
- reducing sugar
- tanning
- active substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 235000000346 sugar Nutrition 0.000 title claims abstract description 18
- 239000002537 cosmetic Substances 0.000 claims abstract description 20
- 150000001875 compounds Chemical class 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 38
- 238000009472 formulation Methods 0.000 claims description 25
- 239000013543 active substance Substances 0.000 claims description 20
- 239000000839 emulsion Substances 0.000 claims description 10
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 5
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 claims description 4
- 229960005193 avobenzone Drugs 0.000 claims description 4
- 229960001679 octinoxate Drugs 0.000 claims description 4
- 230000000475 sunscreen effect Effects 0.000 claims description 4
- 239000000516 sunscreening agent Substances 0.000 claims description 4
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 239000003961 penetration enhancing agent Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 abstract description 17
- 229940120503 dihydroxyacetone Drugs 0.000 abstract description 8
- 239000004480 active ingredient Substances 0.000 abstract 2
- 238000004040 coloring Methods 0.000 abstract 1
- 230000018044 dehydration Effects 0.000 abstract 1
- 238000006297 dehydration reaction Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 21
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000008346 aqueous phase Substances 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000012071 phase Substances 0.000 description 12
- 239000006071 cream Substances 0.000 description 9
- -1 for example DHA Chemical class 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 6
- 229940008099 dimethicone Drugs 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229940075529 glyceryl stearate Drugs 0.000 description 5
- 229940119170 jojoba wax Drugs 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- 239000005662 Paraffin oil Substances 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229940086555 cyclomethicone Drugs 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 229910052710 silicon Inorganic materials 0.000 description 4
- 239000010703 silicon Substances 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 206010033546 Pallor Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 2
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229940100460 peg-100 stearate Drugs 0.000 description 2
- 229940078498 peg-5 glyceryl stearate Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000008389 polyethoxylated castor oil Substances 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 239000008340 white lotion Substances 0.000 description 2
- HNUQMTZUNUBOLQ-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-(2-octadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO HNUQMTZUNUBOLQ-UHFFFAOYSA-N 0.000 description 1
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 1
- SGRCVQDBWHCTIS-UHFFFAOYSA-N 2-nonanoyloxypropyl nonanoate Chemical compound CCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCC SGRCVQDBWHCTIS-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 229920004511 Dow Corning® 200 Fluid Polymers 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000940835 Pales Species 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 206010050637 Skin tightness Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229920002214 alkoxylated polymer Polymers 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 229940073669 ceteareth 20 Drugs 0.000 description 1
- 229940073639 ceteareth-6 Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000008307 w/o/w-emulsion Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Definitions
- the present invention relates to a combination of erythrulose in D- or L-form or as the racemate and at least one additional reducing sugar having self-tanning properties and cosmetic compositions containing these for the artificial tanning of the skin.
- the cosmetic compositions bring about a more even and longer-lasting coloration of the skin and prevent the drying out and uneven peeling thereof compared to known compositions that, for example, contain dihydroxyacetone alone.
- Hydroxyketones and hydroxyaldehydes are known active substances for self-tanning agents.
- the active substances generally processed into creams react with free amino groups of the Stratum corneum and result in brownish-coloured pigments that are bound to proteins of the Stratum corneum.
- the hitherto most frequently used active substance is dihydroxyacetone (hereinafter referred to as “DHA”).
- DHA dihydroxyacetone
- the fast tanning active substance (4-7 hours) does, however, have some disadvantages.
- the skin colour achieved is yellowish-brown, which produces an unnatural colour, particularly in pale skin.
- the tan is irregular and soon pales again because the top-most layers of the epidermis are quickly shed.
- Erythrulose alone can also be used as sole active substance for slightly tanning day creams.
- Erythrulose is a C4-ketosugar of the general structural formula 1,3,4-trihydroxy-butan-2-one that occurs naturally or that can be prepared chemically or biotechnologically in a manner known per se. Erythrulose can be used in D- or L-form or also as the racemate.
- DHA is a C3-ketosugar having the general structural formula 1,3-dihydroxy-propan-2-one that can be prepared in a manner known per se.
- reducing sugars having self-tanning properties that can be used in combination with erythrulose are, for example, glucose, xylose, fructose, reose, ribose, arabinose, allose, tallose, altrose, mannose, galactose, lactose, sucrose, erythrose and glyceraldehyde.
- the active substance combination contains a ratio of erythrulose to reducing sugar of about 10:1 to 1:10, advantageously about ca. 1:1 to 1:3; 1:2 being particularly preferred.
- a cosmetic formulation uses about 1-5% erythrulose and about 1-15% reducing sugar, advantageously about 1.5% erythrulose and 3.5% reducing sugar.
- the stability of erythrulose with a reducing sugar in a cosmetic formulation depends on many factors.
- the active substance combination can be used in O/W (e.g. cream or lotion) and also W/O emulsions and other types of cosmetic formulations (e.g. multiple emulsions such as O/W/O or W/O/W emulsions, gels, ointments, aerosols).
- O/W e.g. cream or lotion
- W/O emulsions and other types of cosmetic formulations e.g. multiple emulsions such as O/W/O or W/O/W emulsions, gels, ointments, aerosols.
- the stability of the active substances can be quantitatively determined using chromatography. To do this, the emulsion is diluted, membrane filtered and analysed using HPLC.
- the oily phase in emulsions can, for example, contain hydrocarbon oils such as paraffin oil or mineral oils, waxes such as beeswax or paraffin wax, silicon oils such as cyclomethicone or dimethicone, fatty alcohols such as stearyl alcohol or cetyl alcohol, natural oils such as jojoba oil, sesame oil or sunflower oil, fatty acid esters such as isopropyl myristate or glyceryl stearate or mono-, di- or triglycerides such as for example caprylic / capric acid triglyceride.
- hydrocarbon oils such as paraffin oil or mineral oils, waxes such as beeswax or paraffin wax, silicon oils such as cyclomethicone or dimethicone, fatty alcohols such as stearyl alcohol or cetyl alcohol, natural oils such as jojoba oil, sesame oil or sunflower oil, fatty acid esters such as isopropyl myristate or
- the oil phase advantageously comprises 5-45% by weight, in particular about 10-30% by weight of the total formulation.
- emulsifiers for oil-in-water and water-in-oil emulsions it is possible to use emulsifiers known per se, such as silicons, sesquioleates, sorbitan esters, alkoxylated sorbitan and fatty acid esters, alkoxylated mono-, di- and triglycerides, optionally alkoxylated polymers such as cross-polymers of ethylene oxide and propylene oxide, optionally alkoxylated fatty alcohols, fatty acids, esters of natural oil derivatives, ethers such as polyethylene glycol(n)stearyl ether and polyethylene cetyl(n)stearyl ether.
- the emulsifiers are advantageously used in amounts of 0.115% by weight related to the total formulation.
- the formulations of the invention may also contain additional auxiliary substances such as for example stabilisers such as mannitol or cyclodextrin, moisturizers such as glycerol and propylene glycol, thickening agents such as acrylic acid polymers or cellulose derivatives, antioxidants such as tocopheryl acetate, pH-correcting agents such as sodium phosphate, film-forming agents such as PVP, preservatives such as phenoxyethanol and paraben, colorants, fragrances, softeners, antiseptics, bactericides, vitamins, pigments,-propellants as well as other compounds that are cosmetically or medicinally desirable.
- stabilisers such as mannitol or cyclodextrin
- moisturizers such as glycerol and propylene glycol
- thickening agents such as acrylic acid polymers or cellulose derivatives
- antioxidants such as tocopheryl acetate
- pH-correcting agents such as sodium phosphate
- film-forming agents such as PVP
- Lipophilic systems are quite generally more suitable for cosmetic formulations of self-tanning agents. Tanning can be accelerated and the colour intensity significantly increased by adding penetration enhancers.
- penetration enhancers dimethicone, cyclomethicone, propylene glycol dipelargonate, propylene glycol or ethoxy diglycol.
- the colour intensity measured was up to 55% higher with formulations containing penetration enhancers as compared to the basic formulation without penetration enhancers.
- Synthetic oils such as Miglyol 812, isopropyl palmitate and silicon oils and natural lipids such as jojoba oil and sesame oil are particularly compatible with the active substance combination and are therefore particularly preferred.
- Gels can also be used as formulation base for the compositions of the invention.
- Carbomers, cellulose derivatives and other gellants can be contained as gel-forming substances.
- the cosmetic formulation is intended to provide both a self-tanning effect and also protection against solar radiation
- sunscreens such as for example octyl methoxycinnamate and/or butyl methoxydibenzoylmethane.
- the active substance combination of the invention, or the cosmetic formulations based thereon, can be applied to the human skin in conventional manner.
- a self-tanning body lotion is prepared by mixing together an oily phase composed of 12.00% Cutina GMS (glyceryl stearate), 1.50% Eumulgin B1 (Ceteareth-12), 1.50% Eumulgin B2 (Ceteareth-20), 4.00% isopropyl myristate, 7.00% paraffin oil and 4.00% Miglyol 812 (caprylic / capric acid triglyceride) and heating to 70° C. and mixing together an aqueous phase composed of 51.20% demineralised water, 0.50% Phenonip and 3.00% glycerol and heating to 75° C.
- Cutina GMS glyceryl stearate
- Eumulgin B1 Ceteareth-12
- Eumulgin B2 Eumulgin B2
- Miglyol 812 caprylic / capric acid triglyceride
- the aqueous phase is then added to the oily phase with stirring and cooled to 50° C., homogenised and cooling continued to 30° C. and an additional aqueous phase composed of 10.00% demineralised water, 1.50% erythrulose and 3.50% dihydroxyacetone is then added to the mixture and stirred until cold. This produces a body lotion that is agreeable to use.
- a self-tanning white lotion is prepared by mixing together an oily phase composed of 1.50% Arlatone 983 S (PEG-5 glyceryl stearate), 2.20% Arlatone 985 (PEG-5 glyceryl stearate), 1.50% Brij 76 (Steareth-10), 5.00% Miglyol 812 (caprylic / capric acid triglyceride), 4.00% paraffin oil and 1.00% silicon oil AK 500 (dimethicone) and heating to 70° C. and mixing together an aqueous phase composed of 59.30% demineralised water, 0.50% Phenonip and 10.00% propylene glycol and heating to 75° C.
- an oily phase composed of 1.50% Arlatone 983 S (PEG-5 glyceryl stearate), 2.20% Arlatone 985 (PEG-5 glyceryl stearate), 1.50% Brij 76 (Steareth-10), 5.00% Miglyol 812 (caprylic
- aqueous phase is then added to the oily phase with stirring and cooled to 50° C., homogenised and cooling continued to 30° C. and an additional aqueous phase composed of 10.00% demineralised water, 1.50% erythrulose and 3.50% dihydroxyacetone is then added to the mixture and stirred until cold. This produces a lotion that is agreeable to use.
- -tanning white lotion is prepared by analogy with Example 2, except that 3.00% erythrulose and 2.00% DHA are used. As in Example 2, this produces a lotion that is agreeable to use.
- a self-tanning cream is prepared by mixing together an oily phase composed of 1.00% Cremophor A6 (Ceteareth 6 and stearyl alcohol), 1.00% Cremophor A25 (Ceteareth 25), 3.00% Cutina GMS (glyceryl stearate), 10.00% paraffin oil, 5.00% jojoba oil and 1.00% cetyl alcohol and heating to 70° C. and mixing together an aqueous phase composed of 48.50% demineralised water, 0.50% Phenonip and 5.00% propylene glycol and heating to 75° C. The aqueous phase is then added to the oily phase with stirring and cooled to 50° C., homogenised and cooling continued to 30° C.
- an oily phase composed of 1.00% Cremophor A6 (Ceteareth 6 and stearyl alcohol), 1.00% Cremophor A25 (Ceteareth 25), 3.00% Cutina GMS (glyceryl stea
- aqueous phase composed of 15.00% demineralised water, 5.00% cyclodextrin, 1.50% erythrulose and 3.50% dihydroxyacetone is then added to the mixture and stirred until cold. This produces a cream that is agreeable to use.
- a self-tanning O/W cream with sunscreen is prepared by mixing together an oily phase composed of 5.00% of a mixture of glyceryl stearate and PEG-100-stearate, 1.00% cetyl alcohol, 2.00% stearic acid, 4.00% dimethicone, 2.00% cyclomethicone, 3.00% caprylic / capric acid triglyceride, 1.00% jojoba oil, 4.00% isopropyl palmitate, 2.00% octyl methoxycinnamate and 1.00% butyl methoxydibenzoylmethane, heating to 75° C. and adding an aqueous phase heated to 80° C.
- a self-tanning W/O/W cream is prepared by preparing an aqueous solution of 2.00% Poloxamer, 0.10% Phenonip, 16.02% demineralised water, 0.38% magnesium sulfate heptahydrate, 1.40% xanthan gum, 0.10% Phenonip, and 20.00% demineralised water and adding 60.00% of a previously prepared W/O emulsion consisting of an oily phase containing 3.30% of a mixture of sorbitan ester and polyglycerol ester, 3.00% polyglycerol ester, 15.00% isohexadecan, 14.00% caprylic / capric acid triglyceride and an aqueous phase with 55.50% demineralised water, 0.20% Phenonip, 0.70% magnesium sulfate heptahydrate, 2.50% erythrulose and 5.80% DHA and homogenising.
- a self-tanning gel is prepared by mixing together 1.00% PVM (copolymer composed of vinyl chloride and vinylmethyl ether) / MA-decadien crosspolymer, 0.50% Phenonip and 83.50% demineralised water, adjusting the pH to 3.7 with sodium hydroxide solution and adding 15% of a mixture of 66.70% demineralised water, 10.00% erythrulose and 23.30% DHA.
- PVM copolymer composed of vinyl chloride and vinylmethyl ether
- MA-decadien crosspolymer 0.50% Phenonip
- demineralised water adjusting the pH to 3.7 with sodium hydroxide solution and adding 15% of a mixture of 66.70% demineralised water, 10.00% erythrulose and 23.30% DHA.
- a self-tanning day cream is prepared by mixing together 5.00% Arlacel 165 (glyceryl stearate, PEG-100-stearate), 1.00% cetyl alcohol, 2.00% stearic acid, 4.00% Dow Corning 200 silicon (dimethicone polymethylsiloxan), 2.00% Belsil CM 020 (cyclomethicone), 3.00% Miglyol 812 (caprylic / capric acid triglyceride), 1.00% jojoba oil, 4.00% isopropyl palmitate, 2.00% Parsol MCX (octyl methoxycinnamate) and 1.00% butyl methoxydibenzoylmethane and heating this oily phase to 70° C.
- Arlacel 165 glyceryl stearate, PEG-100-stearate
- 1.00% cetyl alcohol 2.00% stearic acid
- 4.00% Dow Corning 200 silicon (dimethicone polymethylsiloxan)
- the skin colour was quantified using the “CIE L*a*b* colour system”. This defines the colours in a three-dimensional colour co-ordinate system.
- the a* value corresponds to the red-green axis, the b* value to the yellow-blue axis and the L* value to the pale-dark axis.
- the smaller the L* value the darker the colour.
- the difference between two measuring points in this three-dimensional colour coordinate system can be calculated from the absolute values using the following formula:
- FIG. 1 shows the different influence of the two formulations tested on the colour intensity.
- the diagram shows the percentage colour difference of the combination of erythrulose and DHA compared to DHA.
- the intensity of coloration of the combination erythrulose and DHA was greater.
- the difference in the intensity of coloration of the combination of erythrulose and DHA compared to DHA alone was increasingly more marked because of the delayed decrease in coloration. This shows that erythrulose produces a visible retarded effect.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Treatment And Processing Of Natural Fur Or Leather (AREA)
Abstract
Description
- The present invention relates to a combination of erythrulose in D- or L-form or as the racemate and at least one additional reducing sugar having self-tanning properties and cosmetic compositions containing these for the artificial tanning of the skin. The cosmetic compositions bring about a more even and longer-lasting coloration of the skin and prevent the drying out and uneven peeling thereof compared to known compositions that, for example, contain dihydroxyacetone alone.
- Hydroxyketones and hydroxyaldehydes are known active substances for self-tanning agents. The active substances generally processed into creams react with free amino groups of the Stratum corneum and result in brownish-coloured pigments that are bound to proteins of the Stratum corneum. This conversion of reducing sugars with amino acids, peptides or proteins, known as the Maillard reaction, leads to compounds having a carbonyl function that polymerise to brown melanoids.
- The hitherto most frequently used active substance is dihydroxyacetone (hereinafter referred to as “DHA”). The fast tanning active substance (4-7 hours) does, however, have some disadvantages. The skin colour achieved is yellowish-brown, which produces an unnatural colour, particularly in pale skin. In addition, the tan is irregular and soon pales again because the top-most layers of the epidermis are quickly shed.
- It has now been found that a combination of DHA—or another reducing sugar having similar properties—with erythrulose does not display the above disadvantages. This may be attributed to the fact that erythrulose dyes the skin more slowly (the colour takes about 20-24 hours to develop) and less intensively, but instead also penetrates lower layers of the Stratum corneum where it is also able to react with the free amino groups. This not only results in more even tanning, but also in a retarded effect, with the result that the tan lasts longer. Moreover the skin becomes less dried out than, for example, with DHA alone. The synergistic effect, that will subsequently also be shown with reference to examples, of the active substance combination erythrulose/other reducing sugars, such as for example DHA, was not predictable.
- Erythrulose alone can also be used as sole active substance for slightly tanning day creams. The advantage of erythrulose compared to other reducing sugars having a self-tanning effect, in particular DHA, lies in the fact that the skin is tanned more evenly and without forming undesirable streaks.
- Erythrulose is a C4-ketosugar of the general
1,3,4-trihydroxy-butan-2-one that occurs naturally or that can be prepared chemically or biotechnologically in a manner known per se. Erythrulose can be used in D- or L-form or also as the racemate. DHA is a C3-ketosugar having the generalstructural formula structural formula 1,3-dihydroxy-propan-2-one that can be prepared in a manner known per se. - Other reducing sugars having self-tanning properties that can be used in combination with erythrulose are, for example, glucose, xylose, fructose, reose, ribose, arabinose, allose, tallose, altrose, mannose, galactose, lactose, sucrose, erythrose and glyceraldehyde.
- The active substance combination contains a ratio of erythrulose to reducing sugar of about 10:1 to 1:10, advantageously about ca. 1:1 to 1:3; 1:2 being particularly preferred.
- A cosmetic formulation uses about 1-5% erythrulose and about 1-15% reducing sugar, advantageously about 1.5% erythrulose and 3.5% reducing sugar.
- The stability of erythrulose with a reducing sugar in a cosmetic formulation depends on many factors. The active substance combination can be used in O/W (e.g. cream or lotion) and also W/O emulsions and other types of cosmetic formulations (e.g. multiple emulsions such as O/W/O or W/O/W emulsions, gels, ointments, aerosols). The stability of the active substances can be quantitatively determined using chromatography. To do this, the emulsion is diluted, membrane filtered and analysed using HPLC.
- The oily phase in emulsions can, for example, contain hydrocarbon oils such as paraffin oil or mineral oils, waxes such as beeswax or paraffin wax, silicon oils such as cyclomethicone or dimethicone, fatty alcohols such as stearyl alcohol or cetyl alcohol, natural oils such as jojoba oil, sesame oil or sunflower oil, fatty acid esters such as isopropyl myristate or glyceryl stearate or mono-, di- or triglycerides such as for example caprylic / capric acid triglyceride.
- In the case of oil-in-water emulsions, the oil phase advantageously comprises 5-45% by weight, in particular about 10-30% by weight of the total formulation.
- As emulsifiers for oil-in-water and water-in-oil emulsions it is possible to use emulsifiers known per se, such as silicons, sesquioleates, sorbitan esters, alkoxylated sorbitan and fatty acid esters, alkoxylated mono-, di- and triglycerides, optionally alkoxylated polymers such as cross-polymers of ethylene oxide and propylene oxide, optionally alkoxylated fatty alcohols, fatty acids, esters of natural oil derivatives, ethers such as polyethylene glycol(n)stearyl ether and polyethylene cetyl(n)stearyl ether.
- The emulsifiers are advantageously used in amounts of 0.115% by weight related to the total formulation.
- The formulations of the invention may also contain additional auxiliary substances such as for example stabilisers such as mannitol or cyclodextrin, moisturizers such as glycerol and propylene glycol, thickening agents such as acrylic acid polymers or cellulose derivatives, antioxidants such as tocopheryl acetate, pH-correcting agents such as sodium phosphate, film-forming agents such as PVP, preservatives such as phenoxyethanol and paraben, colorants, fragrances, softeners, antiseptics, bactericides, vitamins, pigments,-propellants as well as other compounds that are cosmetically or medicinally desirable. Examples of other compounds of this nature are set out in the CTFA International Cosmetic Ingredient Dictionary, 6 th edition, The Cosmetic, Toiletry and Fragrance Association, Inc., Washington D.C., 1995.
- Lipophilic systems are quite generally more suitable for cosmetic formulations of self-tanning agents. Tanning can be accelerated and the colour intensity significantly increased by adding penetration enhancers. The following have proved to be particularly suitable as penetration enhancers: dimethicone, cyclomethicone, propylene glycol dipelargonate, propylene glycol or ethoxy diglycol. The colour intensity measured was up to 55% higher with formulations containing penetration enhancers as compared to the basic formulation without penetration enhancers.
- Synthetic oils such as Miglyol 812, isopropyl palmitate and silicon oils and natural lipids such as jojoba oil and sesame oil are particularly compatible with the active substance combination and are therefore particularly preferred.
- Gels can also be used as formulation base for the compositions of the invention. Carbomers, cellulose derivatives and other gellants can be contained as gel-forming substances.
- Insofar as the cosmetic formulation is intended to provide both a self-tanning effect and also protection against solar radiation, it-is also possible to add to the formulation one or several sunscreens, such as for example octyl methoxycinnamate and/or butyl methoxydibenzoylmethane.
- When processing the active substances into cosmetic formulations, care must be taken to ensure that the active substances are only added at lower temperatures of about <40° C. and that the pH value 5 is not exceeded in the cosmetic formulations, this being easily achieved through buffering.
- The active substance combination of the invention, or the cosmetic formulations based thereon, can be applied to the human skin in conventional manner.
- The invention will now be explained in greater detail with reference to examples, the percentages in each case constituting % by weight.
- A self-tanning body lotion is prepared by mixing together an oily phase composed of 12.00% Cutina GMS (glyceryl stearate), 1.50% Eumulgin B1 (Ceteareth-12), 1.50% Eumulgin B2 (Ceteareth-20), 4.00% isopropyl myristate, 7.00% paraffin oil and 4.00% Miglyol 812 (caprylic / capric acid triglyceride) and heating to 70° C. and mixing together an aqueous phase composed of 51.20% demineralised water, 0.50% Phenonip and 3.00% glycerol and heating to 75° C. The aqueous phase is then added to the oily phase with stirring and cooled to 50° C., homogenised and cooling continued to 30° C. and an additional aqueous phase composed of 10.00% demineralised water, 1.50% erythrulose and 3.50% dihydroxyacetone is then added to the mixture and stirred until cold. This produces a body lotion that is agreeable to use.
- A self-tanning white lotion is prepared by mixing together an oily phase composed of 1.50% Arlatone 983 S (PEG-5 glyceryl stearate), 2.20% Arlatone 985 (PEG-5 glyceryl stearate), 1.50% Brij 76 (Steareth-10), 5.00% Miglyol 812 (caprylic / capric acid triglyceride), 4.00% paraffin oil and 1.00% silicon oil AK 500 (dimethicone) and heating to 70° C. and mixing together an aqueous phase composed of 59.30% demineralised water, 0.50% Phenonip and 10.00% propylene glycol and heating to 75° C. The aqueous phase is then added to the oily phase with stirring and cooled to 50° C., homogenised and cooling continued to 30° C. and an additional aqueous phase composed of 10.00% demineralised water, 1.50% erythrulose and 3.50% dihydroxyacetone is then added to the mixture and stirred until cold. This produces a lotion that is agreeable to use.
- A self
- -tanning white lotion is prepared by analogy with Example 2, except that 3.00% erythrulose and 2.00% DHA are used. As in Example 2, this produces a lotion that is agreeable to use.
- A self-tanning cream is prepared by mixing together an oily phase composed of 1.00% Cremophor A6 (Ceteareth 6 and stearyl alcohol), 1.00% Cremophor A25 (Ceteareth 25), 3.00% Cutina GMS (glyceryl stearate), 10.00% paraffin oil, 5.00% jojoba oil and 1.00% cetyl alcohol and heating to 70° C. and mixing together an aqueous phase composed of 48.50% demineralised water, 0.50% Phenonip and 5.00% propylene glycol and heating to 75° C. The aqueous phase is then added to the oily phase with stirring and cooled to 50° C., homogenised and cooling continued to 30° C. and an additional aqueous phase composed of 15.00% demineralised water, 5.00% cyclodextrin, 1.50% erythrulose and 3.50% dihydroxyacetone is then added to the mixture and stirred until cold. This produces a cream that is agreeable to use.
- A self-tanning O/W cream with sunscreen is prepared by mixing together an oily phase composed of 5.00% of a mixture of glyceryl stearate and PEG-100-stearate, 1.00% cetyl alcohol, 2.00% stearic acid, 4.00% dimethicone, 2.00% cyclomethicone, 3.00% caprylic / capric acid triglyceride, 1.00% jojoba oil, 4.00% isopropyl palmitate, 2.00% octyl methoxycinnamate and 1.00% butyl methoxydibenzoylmethane, heating to 75° C. and adding an aqueous phase heated to 80° C. composed of 51.20% demineralised water, 0.50% Phenonip, 6.00% propylene glycol and 2.00% glycerol and stirring thoroughly. The emulsion obtained is cooled to 50° C. and homogenised. At 30° C. an additional aqueous phase composed of 10.00% demineralised water, 1.50% erythrulose and 3.50% dihydroxyacetone is then added and stirred thoroughly.
- A self-tanning W/O/W cream is prepared by preparing an aqueous solution of 2.00% Poloxamer, 0.10% Phenonip, 16.02% demineralised water, 0.38% magnesium sulfate heptahydrate, 1.40% xanthan gum, 0.10% Phenonip, and 20.00% demineralised water and adding 60.00% of a previously prepared W/O emulsion consisting of an oily phase containing 3.30% of a mixture of sorbitan ester and polyglycerol ester, 3.00% polyglycerol ester, 15.00% isohexadecan, 14.00% caprylic / capric acid triglyceride and an aqueous phase with 55.50% demineralised water, 0.20% Phenonip, 0.70% magnesium sulfate heptahydrate, 2.50% erythrulose and 5.80% DHA and homogenising.
- A self-tanning gel is prepared by mixing together 1.00% PVM (copolymer composed of vinyl chloride and vinylmethyl ether) / MA-decadien crosspolymer, 0.50% Phenonip and 83.50% demineralised water, adjusting the pH to 3.7 with sodium hydroxide solution and adding 15% of a mixture of 66.70% demineralised water, 10.00% erythrulose and 23.30% DHA.
- A self-tanning day cream is prepared by mixing together 5.00% Arlacel 165 (glyceryl stearate, PEG-100-stearate), 1.00% cetyl alcohol, 2.00% stearic acid, 4.00% Dow Corning 200 silicon (dimethicone polymethylsiloxan), 2.00% Belsil CM 020 (cyclomethicone), 3.00% Miglyol 812 (caprylic / capric acid triglyceride), 1.00% jojoba oil, 4.00% isopropyl palmitate, 2.00% Parsol MCX (octyl methoxycinnamate) and 1.00% butyl methoxydibenzoylmethane and heating this oily phase to 70° C. In parallel thereto, 57.20% deionised water, 0.50% Phenonip, 6.00% propylene glycol and 2.00% glycerol are mixed and this aqueous phase is heated to 75° C. The aqueous phase is then added to the oily phase with stirring and the mixture cooled to 50° C., homogenised and cooled further to 30° C. A mixture composed of 5.00% deionised water and-4.00% erythrulose is then added and stirred until cold, whereupon the entire mixture is then reacted with 0.30
% Belamie 0/241710. - This produces a day cream that with daily application gives the skin a slightly brownish coloration and healthy appearance. The sunscreens also protect the skin from the effects of harmful UV radiation.
- To investigate the synergistic effect of erythrulose and DHA on the tanning of the skin a tanning study was conducted to compare an O/W lotion containing 1.5% erythrulose and 3.5% DHA according to Example 1 with a lotion containing DHA.
- Fields measuring 10×14 cm were marked on the back of 4 male and 4 female subjects. The subjects were neither allowed to sunbathe nor to visit a solarium during the entire period of the study.
- Before the measurements, the subjects were acclimatised for 15 min in a skin laboratory at 26-28° C. and 40-50% air humidity. Immediately after measuring the initial value on
day 0, the marked test fields were treated with 0.3 ml of the appropriate lotion with light rubbing in. This procedure was repeated on the following 9 days. No more lotion was applied after the 10th day. - From the first day to the 20 th day the colour changes as well as the skin moisture were in each case measured immediately before the next application. The skin moisture was measured using the CM 820 Corneometer (Courage and Khazaka). The skin colour was measured using the Minolta CR 300 Chromameter.
- The skin colour was quantified using the “CIE L*a*b* colour system”. This defines the colours in a three-dimensional colour co-ordinate system. The a* value corresponds to the red-green axis, the b* value to the yellow-blue axis and the L* value to the pale-dark axis. The smaller the L* value, the darker the colour. The difference between two measuring points in this three-dimensional colour coordinate system can be calculated from the absolute values using the following formula:
- ΔE(CIEL*a*b*)={square root}{square root over ((L 1 −*L 2*)+(a 1 *−a 2*)2+(b 1 *−b 2*)2)}
- The value calculated using this formula is a parameter for the colour change of the skin.
- FIG. 1 shows the different influence of the two formulations tested on the colour intensity. The diagram shows the percentage colour difference of the combination of erythrulose and DHA compared to DHA. The use of DHA alone colours the skin faster during the first few days. However, from the 10 th day on, the intensity of coloration of the combination erythrulose and DHA was greater. After application was discontinued, the difference in the intensity of coloration of the combination of erythrulose and DHA compared to DHA alone was increasingly more marked because of the delayed decrease in coloration. This shows that erythrulose produces a visible retarded effect.
- The skin coloration achieved with erythrulose and DHA does not show any streak formation and the skin shows no peeling due to greater drying out.
- Measurements show that the use of erythrulose and DHA in an O/W emulsion causes up to 30% less drying out of the skin (FIG. 2). The skin feels less dry. When using the combination of erythrulose and DHA in comparison to the DHA emulsion, the test subjects did not feel any skin tightness.
Claims (10)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH51897 | 1997-03-05 | ||
| CH518/97 | 1997-03-05 | ||
| PCT/CH1998/000083 WO1998038977A1 (en) | 1997-03-05 | 1998-02-27 | Combination of erythrulose and a reducing sugar with self-browning properties |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20020031482A1 true US20020031482A1 (en) | 2002-03-14 |
| US6451293B1 US6451293B1 (en) | 2002-09-17 |
Family
ID=4188843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/380,651 Expired - Lifetime US6451293B1 (en) | 1997-03-05 | 1998-02-27 | Combination of erythrulose and a reducing sugar with self-tanning properties |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6451293B1 (en) |
| EP (1) | EP1014925B1 (en) |
| JP (1) | JP4065571B2 (en) |
| KR (1) | KR20000075690A (en) |
| AT (1) | ATE304838T1 (en) |
| AU (1) | AU737402B2 (en) |
| CA (1) | CA2282699C (en) |
| CZ (1) | CZ298916B6 (en) |
| DE (1) | DE59813071D1 (en) |
| ES (1) | ES2248890T3 (en) |
| WO (1) | WO1998038977A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070269389A1 (en) * | 2003-12-15 | 2007-11-22 | Rodrigo Fuscelli Pytel | Base Composition for Preparing Multi-Functional Formulations for Care and Protection of the Skin and Hair |
| FR2999912A1 (en) * | 2012-12-21 | 2014-06-27 | Clarins Lab | Cosmetic composition, useful for artificially coloring the skin, providing a natural tan without sun and/or providing good radiant complexion, comprises dihydroxyacetone, extract of aloe gel and/or erythrulose, glycerin, and gelling agent |
| TWI761374B (en) * | 2016-09-30 | 2022-04-21 | 南韓商愛茉莉太平洋股份有限公司 | Skin coloring cosmetic composition |
| US20220151884A1 (en) * | 2019-03-04 | 2022-05-19 | Shiseido Company, Ltd. | Cosmetic emulsion for self-tanning |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002528400A (en) * | 1998-10-26 | 2002-09-03 | ユニバーシティー オブ マサチューセッツ | Skin treatment with adenosine or adenosine analogues |
| DE19857010A1 (en) * | 1998-12-10 | 2000-06-21 | Cognis Deutschland Gmbh | Stable liposomal artificial tanning composition, gives even tan for long periods, obtained by heating aqueous solution of erythrulose and lecithins |
| US6113888A (en) * | 1999-06-15 | 2000-09-05 | Neutrogena Corporation | Self-tanning mousse |
| US20040228810A1 (en) * | 2003-05-13 | 2004-11-18 | Starr Hamson | Sprayable sunless tanning solution with sunscreen protection |
| WO2005004826A1 (en) * | 2003-07-10 | 2005-01-20 | Beiersdorf Ag | Skin toning product comprising a self-browning agent for colour matching of skin regions with different pigmentation |
| US20050100516A1 (en) * | 2003-11-07 | 2005-05-12 | Formulated Solutions, Llc | Hydroalcohol based self-tanning composition |
| US20050239670A1 (en) * | 2004-04-21 | 2005-10-27 | Qing Stella | Personal care compositions that deposit hydrophilic benefit agents |
| US20050238595A1 (en) * | 2004-04-21 | 2005-10-27 | Qing Stella | Personal care compositions that deposit sunless tanning benefit agents |
| US20050238680A1 (en) * | 2004-04-21 | 2005-10-27 | Qing Stella | Personal care compositions that deposit hydrophilic benefit agents |
| JP4231469B2 (en) * | 2004-08-27 | 2009-02-25 | 花王株式会社 | Fake eyebrow cosmetic |
| GB0603167D0 (en) * | 2006-02-17 | 2006-03-29 | Dermasalve Sciences Ltd | Skin application |
| DE102007010986A1 (en) * | 2007-03-05 | 2008-09-11 | Merck Patent Gmbh | Transition-metal-containing effect pigments |
| US20090197819A1 (en) * | 2007-03-20 | 2009-08-06 | Clarence Albert Johnson | Compositions for improving and repairing skin |
| US20080312169A1 (en) * | 2007-03-20 | 2008-12-18 | Clarence Albert Johnson | Cosmetic use of D-ribose |
| US20090063334A1 (en) * | 2007-08-28 | 2009-03-05 | Alistair Duncan | Business-to-business transaction processing utilizing electronic payment network |
| DE102007041475A1 (en) * | 2007-08-31 | 2009-03-05 | Beiersdorf Ag | Active ingredient combination of glycyrrhetinic acid and erythrulose and cosmetic or dermatological preparations containing this combination of active ingredients |
| DE102007041472A1 (en) * | 2007-08-31 | 2009-03-05 | Beiersdorf Ag | Active ingredient combinations of glycyrrhetinic acid and dihydroxyacetone and cosmetic or dermatological preparations containing this combination of active ingredients |
| US20090187060A1 (en) * | 2008-01-22 | 2009-07-23 | E-Z-Em, Inc. | Method and Formulation for Neutralizing Toxic Chemicals and Materials |
| US20090208429A1 (en) * | 2008-02-18 | 2009-08-20 | Conopco, Inc., D/B/A Unilever | Glow and sunless tanning via a heated flowable cosmetic transferred onto skin |
| US20090232750A1 (en) * | 2008-03-13 | 2009-09-17 | St Cyr John A | Compositions for indoor tanning |
| DE102010026776A1 (en) | 2010-07-10 | 2012-01-12 | Merck Patent Gmbh | tanning amplifier |
| US20120128602A1 (en) | 2010-11-19 | 2012-05-24 | Kao Corporation | Skin compositions containing low levels of colorants |
| US8747818B1 (en) | 2011-02-07 | 2014-06-10 | Dennis Gross | Self-tanning compositions |
| JP6813165B2 (en) * | 2016-07-26 | 2021-01-13 | ピアス株式会社 | Pseudo eyebrow forming cosmetics |
| JP6195402B1 (en) * | 2017-03-17 | 2017-09-13 | ウィントレーディング株式会社 | Eyebrows formation method |
| EP3648733B1 (en) * | 2017-07-06 | 2025-08-06 | DSM IP Assets B.V. | Topical compositions |
| ES2964112T3 (en) * | 2019-05-10 | 2024-04-04 | Dsm Ip Assets Bv | Topical compositions with preservation system |
| FR3102929B1 (en) * | 2019-11-08 | 2021-10-22 | Lvmh Rech | Composition containing DHA |
| JP7791838B2 (en) * | 2020-04-29 | 2025-12-24 | 花王株式会社 | Self-tanning compositions containing alkyl sulfonates and methods thereof |
| AU2021265114A1 (en) * | 2020-04-29 | 2022-11-24 | Kao Corporation | Self-tanning compositions containing an aromatic sulfonate and methods thereof |
| EP4059489A1 (en) | 2021-03-19 | 2022-09-21 | IONIQ Skincare GmbH & Co. KG | Electrostatically sprayable tanning formulation |
| EP4609847A1 (en) | 2024-03-01 | 2025-09-03 | IONIQ Skincare GmbH & Co. KG | Electrostatically sprayable tanning formulation |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US401A (en) * | 1837-09-21 | John bouis | ||
| US5569460A (en) * | 1993-06-04 | 1996-10-29 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Skin-coloring preparation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL122394C (en) * | 1960-07-25 | |||
| FR2653334B1 (en) * | 1989-10-19 | 1991-12-20 | Erphar Ste Civile | COSMETIC TANNING PREPARATION. |
| US5302378A (en) * | 1992-06-17 | 1994-04-12 | Chesebrough-Pond's Usa Co. | Self-tanner cosmetic compositions |
| FR2701396B1 (en) * | 1993-02-12 | 1995-04-21 | Oreal | Method for stabilizing vesicles of amphiphilic lipid (s) and composition for topical application containing said stabilized vesicles. |
| US5514367A (en) * | 1994-02-28 | 1996-05-07 | Estee Lauder, Inc. | Skin tanning compositions and methods for their preparation and use |
| FR2732680B1 (en) * | 1995-04-05 | 1997-05-09 | Oreal | CERAMID-LIKE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE |
| US5922333A (en) * | 1997-02-28 | 1999-07-13 | Laughlin Products, Inc. | System for automatically coating the human body |
| FR2772268B1 (en) * | 1997-12-15 | 2000-03-03 | Clarins | NEW COSMETIC SELF-TANNING AND ANTIDEHYDRATING COMPOSITION |
-
1998
- 1998-02-27 US US09/380,651 patent/US6451293B1/en not_active Expired - Lifetime
- 1998-02-27 AU AU62033/98A patent/AU737402B2/en not_active Expired
- 1998-02-27 CZ CZ0308399A patent/CZ298916B6/en not_active IP Right Cessation
- 1998-02-27 KR KR1019997007757A patent/KR20000075690A/en not_active Ceased
- 1998-02-27 JP JP53802898A patent/JP4065571B2/en not_active Expired - Lifetime
- 1998-02-27 AT AT98903980T patent/ATE304838T1/en not_active IP Right Cessation
- 1998-02-27 ES ES98903980T patent/ES2248890T3/en not_active Expired - Lifetime
- 1998-02-27 EP EP98903980A patent/EP1014925B1/en not_active Expired - Lifetime
- 1998-02-27 WO PCT/CH1998/000083 patent/WO1998038977A1/en not_active Ceased
- 1998-02-27 CA CA002282699A patent/CA2282699C/en not_active Expired - Lifetime
- 1998-02-27 DE DE59813071T patent/DE59813071D1/en not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US401A (en) * | 1837-09-21 | John bouis | ||
| US5569460A (en) * | 1993-06-04 | 1996-10-29 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Skin-coloring preparation |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070269389A1 (en) * | 2003-12-15 | 2007-11-22 | Rodrigo Fuscelli Pytel | Base Composition for Preparing Multi-Functional Formulations for Care and Protection of the Skin and Hair |
| FR2999912A1 (en) * | 2012-12-21 | 2014-06-27 | Clarins Lab | Cosmetic composition, useful for artificially coloring the skin, providing a natural tan without sun and/or providing good radiant complexion, comprises dihydroxyacetone, extract of aloe gel and/or erythrulose, glycerin, and gelling agent |
| TWI761374B (en) * | 2016-09-30 | 2022-04-21 | 南韓商愛茉莉太平洋股份有限公司 | Skin coloring cosmetic composition |
| US20220151884A1 (en) * | 2019-03-04 | 2022-05-19 | Shiseido Company, Ltd. | Cosmetic emulsion for self-tanning |
Also Published As
| Publication number | Publication date |
|---|---|
| AU6203398A (en) | 1998-09-22 |
| ES2248890T3 (en) | 2006-03-16 |
| ATE304838T1 (en) | 2005-10-15 |
| WO1998038977A1 (en) | 1998-09-11 |
| AU737402B2 (en) | 2001-08-16 |
| CA2282699A1 (en) | 1998-09-11 |
| KR20000075690A (en) | 2000-12-26 |
| EP1014925B1 (en) | 2005-09-21 |
| EP1014925A1 (en) | 2000-07-05 |
| DE59813071D1 (en) | 2005-10-27 |
| CZ298916B6 (en) | 2008-03-12 |
| CZ308399A3 (en) | 2000-02-16 |
| JP2001513780A (en) | 2001-09-04 |
| CA2282699C (en) | 2007-09-18 |
| JP4065571B2 (en) | 2008-03-26 |
| US6451293B1 (en) | 2002-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU737402B2 (en) | Combination of erythrulose and a reducing sugar with self-tanning properties | |
| AU684483B2 (en) | Self-tanning cosmetic compositions and methods of using the same | |
| US6328987B1 (en) | Cosmetic skin care compositions containing alpha interferon | |
| EP0686023B1 (en) | Sunscreens containing oat extracts | |
| CA2153324C (en) | Cosmetic compositions containing surface treated pigments | |
| US4603046A (en) | Improved sunscreen or sunblock composition | |
| AU710889B2 (en) | Skin tanning compositions and method | |
| HK1002826B (en) | Cosmetic compositions containing surface treated pigments | |
| US20070189989A1 (en) | Cosmetic compositions and methods of making and using the compositions | |
| JPH10513188A (en) | Composition for makeup makeup | |
| BRPI0818100B1 (en) | method for protecting low viscosity hydrophobic active liquids in personal care composition | |
| US8545859B2 (en) | Use of acrylates copolymer as waterproofing agent in personal care applications | |
| WO2005077328A1 (en) | Anti-wrinkle cosmetic | |
| JP2003504319A (en) | Self-tanning composition containing DHA and propolis extract | |
| CN115252458A (en) | Stable moisturizing composition containing blue copper peptide | |
| JP2004131401A (en) | Skin cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: PENTAPHARM AG, SWITZERLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SCHREIER, THOMAS;JERMANN, ROLAND;REEL/FRAME:010361/0475 Effective date: 19990823 |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| FPAY | Fee payment |
Year of fee payment: 4 |
|
| FEPP | Fee payment procedure |
Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| FPAY | Fee payment |
Year of fee payment: 8 |
|
| AS | Assignment |
Owner name: DSM IP ASSETS B.V., NETHERLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PENTAPHARM AG;REEL/FRAME:024630/0609 Effective date: 20071215 |
|
| SULP | Surcharge for late payment | ||
| FPAY | Fee payment |
Year of fee payment: 12 |